EWBC vs GILD · P/E 13, rev $2.14B vs P/E 18, rev $7.80B
East West Bancorp Inc (EWBC) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
East West Bancorp Inc (EWBC) is a banks - regional company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported EWBC revenue for 2026-06-30 was $2.14B. Net income was $721.5M. EWBC currently screens at market cap $14.74B and trailing P/E 12.8.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
EWBC currently screens at market cap $14.74B and trailing P/E 12.8. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the EWBC and GILD stock pages for the full models.
Not investment advice.